Journal Report

International Clinical Psychopharmacology

Download PDF
Journal Information
Journal Title
International Clinical Psychopharmacology
Publisher
ISSN
0268-1315
E-ISSN
Database
AERES
Domain
Health Sciences, Life Sciences, Social Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Attributing benefit and harm in clinical practice: medication burden, causality, and pharmacovigilance
Alessandro Serretti
2026-9-30 Vol. 41 Issue 6 Pages 319-323
DOI: 10.1097/yic.0000000000000639
Lithium-associated peripheral transcriptional signatures correlate with brain white matter microstructure in bipolar disorder
Diana Betelli, Serena Furno, Beatrice Bravi et al.
2026-9-4
DOI: 10.1097/yic.0000000000000637
Use of risperidone in-situ microparticles in real world: patterns of prescription and dose selection in patients with psychotic disorders
Ilaria Di Bernardo, Paolo Brambilla, D’Agostino Armando et al.
2026-9-2
DOI: 10.1097/yic.0000000000000634
Efficacy and safety of intramuscular and intravenous midazolam for acute agitation in emergency settings: a systematic review
Federico Bottaro, Guido Nosari, Isidora Tesic et al.
2026-8-25
DOI: 10.1097/yic.0000000000000638
Not all antipsychotic polypharmacy is the same
Norio Yasui-Furukori
2026-7-29 Vol. 41 Issue 5 Pages 304-307
DOI: 10.1097/yic.0000000000000629
Association between anxious depression and clinical outcomes in subjects with treatment-resistant depression: a comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment-resistant depression (ASCERTAIN-TRD)
Stefania Chaikali, Clotilde Guidetti, Silvia Ioannou et al.
2026-7-29 Vol. 41 Issue 5 Pages 295-303
DOI: 10.1097/yic.0000000000000628
Preliminary evidence that blood extracellular nicotinamide phosphoribosyltransferase increases with antidepressant response to chronotherapeutics and to monoaminergic drugs
Francesco Benedetti, Igor Branchi, Ha Kyung Shin et al.
2026-7-29 Vol. 41 Issue 5 Pages 277-283
DOI: 10.1097/yic.0000000000000622
Methylphenidate treatment in adults with comorbid attention-deficit/hyperactivity disorder and borderline personality disorder: a prospective longitudinal study
Giulio Emilio Brancati, Martina Marcenaro, Elena Costagli et al.
2026-7-29 Vol. 41 Issue 5 Pages 284-294
DOI: 10.1097/yic.0000000000000630
Drug development in autism spectrum disorder: genetic heterogeneity, failed trials, and the case for stratified pharmacotherapy
Riccardo Bortoletto, Giuseppe Fanelli, Marco Colizzi
2026-7-29 Vol. 41 Issue 5 Pages 308-311
DOI: 10.1097/yic.0000000000000627
Resistant depression, biomarkers, and comorbidity in clinical practice
Alessandro Serretti
2026-7-29 Vol. 41 Issue 5 Pages 265-268
DOI: 10.1097/yic.0000000000000633
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 11, 2026 10:25